| Literature DB >> 25998619 |
Shyamala Maheswaran1, Daniel A Haber1.
Abstract
With increasing application of targeted therapies and the development of acquired resistance, much attention is being focused on developing in vitro and in vivo patient-specific tumor models for individualized therapeutic evaluation of cancers. Circulating tumor cells provide a source of noninvasively and sequentially sampled invasive cancer cells suitable for propagation in vitro. We review the advantages and challenges associated with ex vivo culture of tumor cells circulating in the blood of patients with cancer. ©2015 American Association for Cancer Research.Entities:
Mesh:
Year: 2015 PMID: 25998619 PMCID: PMC4470788 DOI: 10.1158/0008-5472.CAN-15-0145
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701